Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 288.19M
March 31, 2026 329.46M
December 31, 2025 307.53M
September 30, 2025 330.84M
June 30, 2025 371.44M
March 31, 2025 417.94M
December 31, 2024 471.39M
September 30, 2024 519.26M
June 30, 2024 564.12M
March 31, 2024 547.86M
December 31, 2023 620.18M
September 30, 2023 672.25M
June 30, 2023 660.46M
March 31, 2023 686.18M
December 31, 2022 710.41M
September 30, 2022 495.63M
June 30, 2022 508.80M
March 31, 2022 542.99M
December 31, 2021 579.09M
September 30, 2021 600.10M
June 30, 2021 401.18M
March 31, 2021 344.34M
December 31, 2020 296.73M
September 30, 2020 315.88M
June 30, 2020 333.94M
Date Value
March 31, 2020 352.68M
December 31, 2019 375.72M
September 30, 2019 390.30M
June 30, 2019 399.50M
March 31, 2019 411.46M
December 31, 2018 427.66M
September 30, 2018 451.51M
June 30, 2018 486.21M
March 31, 2018 429.04M
December 31, 2017 417.62M
September 30, 2017 456.06M
June 30, 2017 471.73M
March 31, 2017 506.55M
December 31, 2016 386.92M
September 30, 2016 408.57M
June 30, 2016 442.95M
March 31, 2016 474.25M
December 31, 2015 370.59M
September 30, 2015 387.80M
June 30, 2015 402.39M
March 31, 2015 279.86M
December 31, 2014 293.58M
September 30, 2014 306.15M
June 30, 2014 303.85M
March 31, 2014 195.05M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Alkermes Plc 656.58M
Amarin Corp. Plc 314.85M
Agenus, Inc. 18.74M
Amgen, Inc. 13.99B
Anika Therapeutics, Inc. 38.41M